🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 20, 2026

Iterum Therapeutics Revenue

Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's total for the last twelve months to $390.00K. That makes Iterum Therapeutics the 44,848th largest company in the world by revenue and 6,423rd in the United States.

Revenue (ttm)
390.00K
Revenue Growth
n/a
P/S Ratio
0.00
Revenue / Employee
43.33K
Employees
9
Market Cap
53.00

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Gelesis Holdings12.14M
Baudax Bio1.27M
Mymetics564.14K
Core One Labs338.91K
0913693 B.C.249.09K
Panacos Pharmaceuticals99.00K
Athersys80.00K
Revenue Rankings